Myriam Curet Sells 2,401 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $205,093. The trade was a 87.18 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Tuesday, February 11th, Myriam Curet sold 408 shares of Intuitive Surgical stock. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00.

Intuitive Surgical Stock Up 1.7 %

ISRG stock opened at $573.15 on Friday. The stock has a market capitalization of $204.14 billion, a P/E ratio of 89.42, a P/E/G ratio of 5.85 and a beta of 1.39. The firm has a 50-day simple moving average of $569.87 and a 200-day simple moving average of $528.64. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Institutional Trading of Intuitive Surgical

Institutional investors and hedge funds have recently modified their holdings of the stock. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $26,000. Parvin Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $28,000. Finally, Hurley Capital LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at about $28,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of several research reports. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Truist Financial lifted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Barclays lifted their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Finally, CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.